Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT06981442

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

Led by Institute of Tropical Medicine, Belgium · Updated on 2025-05-20

2050

Participants Needed

1

Research Sites

92 weeks

Total Duration

On this page

Sponsors

I

Institute of Tropical Medicine, Belgium

Lead Sponsor

I

Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

Collaborating Sponsor

AI-Summary

What this Trial Is About

Arboviral diseases are viral diseases transmitted by mosquitoes of the Aedes genus and are constantly spreading throughout the world, constituting a significant threat to public health. In Africa, there is very little data on the epidemiological situation of Aedes-borne diseases and programs for monitoring these diseases are very limited. In the Democratic Republic of the Congo (DRC), several epidemics of yellow fever, dengue fever, chikungunya and Zika cases have been reported. In particular, in Kinshasa, the dengue and chikungunya viruses have previously been detected in patients with undifferentiated fevers and several studies have shown entomological transmission indices above the criteria and standards of the World Health Organization (WHO). The aim of our study is to implement and evaluate different strategies to control Aedes mosquitoes at different stages of their life cycle in the city of Kinshasa. In particular, a before-and-after interventional study will be piloted and tested in the health zone of Kinshasa, with the aim of providing preliminary evidence of the impact of vector control tools. Interventions will be implemented in 400 households for each arm for 12 months. Before, after and during the interventions, entomological surveys will be conducted in 160 households in each arm to define the density of the vectors. Mosquitoes will be tested for the possible presence of arbovirus RNA (dengue, chikungunya, Zika, yellow fever). During the pre-intervention period, a serological survey for the same diseases transmitted by the Aedes mosquito will be conducted on a sample of 450 people included in two health centers of reference for the health zone of Mont Ngafula 1. A questionnaire will also be administered before and after the intervention implementation to assess the community's knowledge, attitudes and practices towards Aedes mosquito vector control and Aedes-borne diseases. The integration of the data collected within the scope of this study will provide an assessment of the feasibility and impact of the tested methods on entomological indicators, as well as determining the exposure and knowledge of Aedes-borne diseases in the Mont Ngafula 1 area.

CONDITIONS

Official Title

Implementation and Evaluation of Vector Control Methods in Kinshasa: The Case of Aedes

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Belong to a household in one of the 4 health areas selected as study arms
  • Be 18 years of age or older to consent for household enrollment and participation in the serosurvey
  • Provide consent to participate
  • Be a resident of the health zone of Mont Ngafula 1 (for health facility participants)
Not Eligible

You will not qualify if you...

  • Not belong to a household in one of the 4 health areas selected as study arms
  • Be under 18 years of age
  • Not provide consent to participate
  • Not be a resident in the health zone of Mont Ngafula 1 (for health facility participants)
  • Be seriously ill, hospitalized, requiring transfusion, have blood clotting disorders, allergies from injections, adverse events from previous blood sampling, or be pregnant

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut National de Recherche Biomédicale, INRB

Kinshasa, République Démocratique Du Congo, Democratic Republic of the Congo

Actively Recruiting

Loading map...

Research Team

L

Luciana Lepore

CONTACT

W

Wim Van Bortel

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here